Global Custom Antibody Market Report and Forecast 2024-2032

Global Custom Antibody Market Outlook

The global custom antibody market size was valued at USD 393.3 million in 2023, driven by rising demand for personalised medicine across the globe. The market is expected to grow at a CAGR of 12.7% during the forecast period of 2024-2032, with the values likely to rise from USD 443.1 million in 2024 to USD 1149.1 million by 2032.

Custom Antibody: Introduction

Custom antibodies are specifically designed for research or diagnostic purposes. It involves generating antibodies that target specific antigens of interest through immunizing an animal, mostly, a rabbit or a mouse. They can be tailored for various applications like western blotting, ELISA, flow cytometry and other lab techniques. Custom antibodies play a crucial role when the usual antibodies do not meet the needs for a research project.

Global Custom Antibody Market Analysis

The biopharmaceutical industry has seen significant growth in recent years. With focus on biologics, monoclonal antibodies, and personalized medicine to treat chronic diseases like cancer and autoimmune disorders, the custom antibody market demand has grown.

The market growth is driven by the rising technical advancements in the antibody research domain. Numerous companies are expanding their biopharmaceutical division to develop efficient and better solutions for patients. In May 2023, Biosynth acquired United Kingdom based Cambridge Research Biochemicals, an independent producer and custom-made peptide and antibody tools. This acquisition is projected to benefit both United States and Europe population, as the companies aim at generating novel, or complex monoclonal as well as polyclonal antibodies that are not present in catalogs.

China based Biocytogen Pharmaceuticals Co. Ltd. revealed the expansion of their company into two new divisions in August 2023. These divisions are designed to focus on animal models and preclinical services along with development and discovery of new antibody-based drugs for out-licensing and partnerships. Such expansions will play a critical role in catering to the increasing demand for pharmaceuticals and will benefit the custom antibody market value significantly in upcoming years.

Global Custom Antibody Market Segmentation

Market Breakup by Product Type

• Monoclonal Antibodies

• Polyclonal Antibodies

• Recombinant Antibodies

• Others

Market Breakup by Services

• Antibody Development

• Antibody Production and Purification

• Antibody Fragmentation and Labelling

• Others

Market Breakup by Source

• Mice

• Rabbit

• Others

Market Breakup by Application

• Oncology

• Infectious Diseases

• Neurology

• Stem cells

• Immunology

• Cardiovascular Diseases

• Others

Market Breakup by End User

• Pharmaceutical and Biotechnology Companies

• Academic and Research Institutes

• CRO

• Hospitals and Clinics

• Others

Market Breakup by Distribution Channel

• Direct Tender

• Third Party Distributors

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Custom Antibody Market Overview

The United States has dominated the custom antibody market share globally. The market size can be accredited to a well-developed research infrastructure, along with the presence of influential pharmaceutical companies working seamlessly to develop more drugs and therapeutics. Moreover, the advent of artificial intelligence and digitally enabled tools is also helping to make the drug development processes rapid and precise.

In Europe, antimicrobial resistance is a key area of attention amongst researchers. As a result, there is increased attention on adopting new technologies for effective antibody-based drugs. Having prominent research and academic institutions home is anticipated to contribute to contribute to the market growth significantly.

The Asia Pacific region is also poised to witness substantial custom antibody market value growth. Influential economies like India, Japan, Singapore, and China are continuously working towards improving the medical ecosystem. India is experiencing significant development with the launch of government initiatives like PRIP (Promotion of Research and Innovation in Pharma MedTech Sector) along with growing privatisation, which can be considered as a major driver for market growth in the forecast period.

Global Custom Antibody Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Thermo Fisher Scientific Inc.

• Creative Diagnostics

• Abcam plc.

• Bio-Rad Laboratories, Inc

• Kaneka Eurogentec S.A.

• YenZym Antibodies, LLC.

• Abmart

• Labcorp Drug Development

• LifeSpan BioSciences, Inc.

• GenScript

• Agilent Technologies

• Proteogenix

• Raybiotech, Inc.

• ProSci Incorporated

• Innovagen AB

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

Custom Antibody Market Report Snapshots

Custom Antibody Market Size

Custom Antibody Market Analysis

Custom Antibody Companies